CHARLOTTESVILLE, Va. (CBS19 NEWS) -- Researchers at UVA Health are hoping that their latest efforts will lead to an approach to detecting patients at risk of interstitial lung disease, an increasingly common condition that is a leading reason for lung transplants.
Led by Dr. John Kim, they believe that certain biological indicators in the blood — already useful in predicting the survival of ILD patients — can also be used to predict whether people will develop the disease at all.